viral
respiratori
tract
infect
common
caus
hospit
mortal
infant
young
children
influenza
influenza
b
parainfluenza
human
rhinoviru
adenoviru
respiratori
syncyti
viru
metapneumoviru
coronaviru
recogn
viral
agent
associ
respiratori
tract
infect
therefor
need
rapid
sensit
differenti
diagnosi
respiratori
viral
pathogen
prevent
nosocomi
infect
minim
unnecessari
antibiot
usag
exist
standard
nonmolecular
diagnost
method
viral
cultur
immunofluoresc
dfa
timeconsum
labor
intens
low
sensit
accordingli
molecular
techniqu
increasingli
accept
diagnosi
viral
respiratori
tract
infect
last
year
multiplex
rtpcr
assay
develop
detect
respiratori
virus
commerci
xtag
rvp
luminex
multicod
plx
rvp
eragen
bioscienc
resplex
ii
qiagen
previou
studi
multiplex
pcr
base
genomelab
gene
express
profil
gexp
analyz
shown
effect
detect
pandem
influenza
viru
nine
serotyp
enterovirus
associ
hand
foot
mouth
diseas
sixteen
differ
respiratori
viru
typessubtyp
singl
tube
howev
method
like
wide
adopt
provinci
center
diseas
control
prevent
due
limit
avail
gexp
equip
therefor
studi
twotub
multiplex
revers
transcript
pcr
assay
twotub
assay
detect
sixteen
respiratori
virus
base
amplicon
size
differ
use
autom
electrophoresi
system
describ
one
tube
use
simultan
detect
nine
respiratori
virus
includ
influenza
viru
flua
influenza
b
viru
flub
season
influenza
viru
subtyp
parainfluenza
viru
type
human
rhinoviru
hrv
coronaviru
subtyp
cov
coronaviru
subtyp
cov
coronaviru
subtyp
cov
adenoviru
adv
anoth
tube
use
simultan
detect
seven
respiratori
virus
includ
parainfluenza
viru
type
parainfluenza
viru
type
respiratori
syncyti
viru
rsva
respiratori
syncyti
viru
b
rsvb
coronaviru
subtyp
cov
human
metapneumoviru
hmpv
human
bocaviru
hbov
twotub
assay
use
qiaxcel
autom
electrophoresi
system
access
provinci
center
diseas
control
prevent
china
twotub
assay
may
greater
potenti
routin
surveil
respiratori
viru
infect
china
improv
capac
emerg
manag
total
nasopharyng
aspir
collect
children
hospit
beij
china
june
march
hospit
children
two
year
age
present
acut
lower
respiratori
infect
alri
syndrom
base
clinic
measur
recommend
world
health
organ
patient
includ
studi
accord
follow
criteria
parenchym
infiltr
chest
radiographi
dri
moist
rale
bodi
temperatur
c
normal
low
leukocyt
count
lower
chest
wall
indraw
mean
age
studi
particip
month
case
particip
male
femal
total
particip
urban
area
suburban
rural
area
china
hebei
henan
shanxi
shandong
inner
mongolia
specimen
collect
within
day
symptom
onset
patient
bacteri
infect
exclud
aspect
studi
perform
accord
nation
ethic
regul
approv
institut
review
board
center
diseas
control
prevent
china
children
parent
appris
studi
purpos
right
keep
inform
confidenti
written
consent
obtain
children
parent
total
rnadna
extract
l
clinic
sampl
use
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
extract
elut
l
dnaseand
rnasefre
water
store
c
nine
pair
chimer
primer
ad
tube
detect
nine
respiratori
virus
eight
pair
chimer
primer
ad
tube
detect
seven
respiratori
virus
one
pair
intern
control
primer
one
pair
univers
primer
ad
tube
sequenc
human
genom
rnase
p
gene
use
intern
control
primer
specimen
primer
sequenc
target
gene
amplicon
size
primer
work
concentr
list
tabl
step
rtpcr
kit
qiagen
hilden
germani
use
amplif
total
l
pcr
mixtur
contain
l
extract
rna
vari
primer
concentr
tabl
subject
follow
condit
c
min
c
min
follow
cycl
c
c
c
cycl
c
c
c
cycl
c
c
c
final
incub
c
min
reaction
analyz
qiaxcel
automat
electrophoresi
use
qiaxcel
dna
highresolut
kit
specif
twotub
assay
viral
target
test
individu
two
multiplex
reaction
experiment
condit
describ
previous
cellcultur
viru
stock
contain
nattrol
respiratori
valid
panel
zeptometrix
buffalo
new
york
usa
use
posit
control
flua
flub
hrv
adv
rsva
rsvb
hmpv
cov
cov
valid
specif
specimen
genotyp
previous
use
posit
control
hbov
cov
determin
analyt
sensit
assay
serial
dilut
viral
rna
transcript
rna
virus
serial
dilut
plasmid
contain
adv
hbov
target
sequenc
analyz
twotub
assay
pcr
product
clone
pgemt
vector
use
transform
cell
plasmid
dna
extract
ezna
plasmid
mini
kit
omega
ga
usa
rna
copi
number
calcul
measur
concentr
rna
transcrib
vitro
use
largescal
rna
product
system
promega
wisconsin
usa
dna
virus
adv
hbov
vitro
transcript
omit
sensit
twotub
assay
examin
use
premix
quantit
viral
rna
transcript
plasmid
personnel
respons
read
assay
experienc
staff
basic
train
microbiolog
molecular
biolog
luminex
xtag
rvp
fast
kit
abbott
illinoi
usa
enabl
user
detect
simultan
flua
flub
rsv
adv
hmpv
cov
enteroviru
hev
hrv
hbov
rnadna
extract
clinic
specimen
test
use
luminex
xtag
rvp
fast
assay
plate
format
accord
manufactur
instruct
plate
analyz
use
bioplex
system
biorad
ca
usa
median
fluoresc
intens
mfi
determin
addit
target
detect
twotub
assay
confirm
independ
pcr
sequenc
expect
size
viru
typesubtypespecif
amplicon
observ
separ
clearli
viral
target
qiaxcel
automat
electrophoresi
posit
control
misprim
primer
dimer
amplif
neg
control
observ
either
tube
figur
qiaxcel
dna
high
resolut
kit
capabl
resolv
amplicon
littl
bp
size
differ
smallest
size
differ
test
bp
viral
target
use
clinic
specimen
posit
control
hbov
cov
cov
singl
pcr
product
detect
addit
intern
control
peak
bp
sensit
assay
evalu
viru
typesubtyp
individu
use
serial
tenfold
dilut
rang
copi
clone
pcr
product
two
tube
limit
detect
hrv
rsva
hbov
adv
copi
per
reaction
copi
per
reaction
viru
typesubtyp
assay
studi
sensit
twotub
assay
viral
target
present
also
test
detect
sensit
tube
premix
viral
target
copi
per
reaction
copi
per
reaction
tube
premix
templat
figur
specimen
compar
detect
doubleblind
test
perform
train
staff
laboratori
specimen
assay
luminex
xtag
rvp
fast
assay
retest
twotub
assay
two
assay
detect
presenc
least
one
assay
virus
specimen
two
assay
detect
viru
specimen
twotub
assay
detect
viru
specimen
neg
luminex
xtag
rvp
fast
assay
adv
rsvb
hrv
specimen
posit
detect
hrv
luminex
xtag
rvp
fast
assay
luminex
xtag
rvp
fast
assay
identifi
specimen
coinfect
complet
agreement
assay
detect
virus
specimen
miss
twotub
assay
addit
virus
coinfect
specimen
detect
twotub
assay
coinfect
specimen
gave
inconsist
result
two
assay
tabl
shown
tabl
viral
infect
identifi
twotub
assay
viral
infect
found
luminex
xtag
rvp
fast
assay
infect
event
detect
luminex
xtag
rvp
fast
assay
includ
hrv
hmpv
adv
rsva
rsvb
thirtytwo
undetect
target
found
coinfect
remain
target
adv
rsvb
hrv
singletarget
posit
specimen
twotub
assay
twotub
assay
fail
detect
follow
viral
infect
hrv
adv
hbov
sixteen
specimen
coinfect
remain
target
posit
hrv
specimen
hrv
primer
use
luminex
xtag
rvp
fast
assay
abl
amplifi
hrv
enteroviru
specimen
posit
hrv
detect
luminex
xtag
rvp
fast
assay
could
enterovirus
sensit
specif
neg
predict
valu
npv
posit
predict
valu
ppv
accord
rate
kappa
valu
viru
twotub
assay
compar
luminex
xtag
rvp
fast
assay
refer
shown
tabl
addit
target
detect
twotub
assay
confirm
sequenc
true
posit
specimen
discord
result
twotub
rvp
assay
seeplex
ace
detect
kit
use
resolv
discrep
tabl
confirm
result
defin
result
detect
least
two
three
pcr
assay
result
sequenc
sensit
specif
neg
predict
valu
npv
posit
predict
valu
ppv
accord
rate
kappa
valu
viru
twotub
assay
compar
confirm
result
refer
shown
tabl
studi
novel
twotub
assay
base
qiaxcel
capillari
electrophoresi
replac
gexp
evalu
potenti
applic
routin
laboratori
test
respiratori
virus
china
optim
work
condit
twotub
assay
reveal
good
specif
without
nonspecif
amplif
use
size
detect
system
though
convent
valid
specif
usual
done
probe
detect
hybrid
nest
pcr
sequenc
twotub
assay
achiev
sensit
copi
per
reaction
assay
individu
viru
typesubtyp
copi
viral
target
present
tube
copi
viral
templat
present
tube
result
suggest
util
twotub
assay
detect
multipl
respiratori
viru
infect
laboratori
equip
perform
liquid
chipbas
multiplex
assay
specimen
hospit
children
show
high
preval
infect
coinfect
common
respiratori
viral
pathogen
hrv
found
frequent
follow
rsvb
major
discrep
twotub
assay
introduc
studi
luminex
xtag
rvp
fast
assay
found
detect
hrv
adv
hbov
rsvb
kappa
resp
tabl
hrv
posit
sampl
includ
detect
twotub
assay
confirm
sequenc
posit
hrv
hrvposit
specimen
detect
luminex
xtag
rvp
fast
assay
could
enterovirus
luminex
rvp
fast
assay
detect
enteroviru
hev
compon
hevhrv
resolv
seeplex
ace
detect
kit
three
truli
discord
adv
seven
specimen
identifi
posit
twotub
assay
shown
via
sequenc
adv
c
adv
one
advposit
specimen
miss
twotub
assay
hbov
five
specimen
detect
posit
luminex
xtag
rvp
fast
assay
also
neg
seeplex
assay
posit
sampl
detect
twotub
assay
rsvb
rsva
hmpv
confirm
sequenc
true
posit
flua
posit
sequenc
twotub
assay
fail
detect
posit
detect
result
coronavirus
cov
cov
cov
cov
influenza
flua
flub
complet
consist
two
assay
summari
fals
posit
found
twotub
assay
total
fals
neg
occur
hrv
adv
twotub
assay
sensit
luminex
xtag
rvp
fast
assay
detect
hrv
rsvb
adv
adv
c
overal
detect
rate
twotub
assay
viru
compar
luminex
xtag
rvp
fast
assay
kappa
demonstr
high
sensit
specif
twotub
assay
analysi
clinic
sampl
twotub
assay
confirm
luminex
xtag
rvp
fast
assay
reveal
almost
respiratori
specimen
test
posit
least
one
viral
infect
viral
coinfect
frequent
overal
coinfect
rate
twotub
assay
luminex
xtag
rvp
fast
assay
respect
compar
similar
report
extrem
higher
coinfect
rate
found
assay
might
due
differ
test
popul
possibl
nosocomi
infect
hospit
routin
use
extens
test
method
twotub
assay
make
larg
studi
clinic
relev
singl
multipl
respiratori
viru
infect
feasibl
clinic
relev
outcom
multiplex
pcr
test
respiratori
virus
yet
fulli
determin
one
studi
children
rsv
infect
higher
fever
longer
hospit
stay
frequent
use
antibiot
associ
multipl
infect
agent
influenza
b
viru
posit
test
may
provid
basi
antivir
treatment
suggest
rapid
etiolog
diagnosi
viral
rti
could
reduc
unnecessari
prescript
antibiot
remain
shown
two
distinct
advantag
twotub
assay
short
assay
time
low
cost
assay
requir
hour
complet
sampl
includ
half
hour
prepar
pcr
mixtur
whole
rtpcr
hour
detect
qiaxcel
automat
electrophoresi
minut
use
liquid
chipbas
assay
might
take
entir
workday
cost
twotub
assay
includ
rtpcr
kit
consum
detect
versu
least
use
liquid
chipbas
assay
conclus
twotub
assay
develop
studi
use
automat
capillari
electrophoresi
rapid
costeffect
method
high
sensit
specif
detect
respiratori
viru
infect
demonstr
great
potenti
routin
surveil
respiratori
viru
infect
